Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
Pancreas|October 25, 2013
Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinomaHemchandra Mahaseth, Edith Brutcher, John Kauh, et al.
Molecular Carcinogenesis|April 30, 2016
Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancerBalney Rajitha, Ganji Purnachandra Nagaraju, Walid L Shaib, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancerAnthony B El-Khoueiry, John Sarantopoulos, Cindy L O'Bryant, et al.
Cancer Letters|August 13, 2013
Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancerGanji Purnachandra Nagaraju, Shijun Zhu, Jing Wen, et al.
Cancer Treatment and Research Communications|February 20, 2021
Impact of high-risk features for stage II adenocarcinoma of the appendixMehmet Akce, Katerina Zakka, McKenna Penley, et al.
Journal of Surgical Oncology|October 30, 2020
Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomesOlatunji B Alese, Katerina Zakka, Xingyue Huo, et al.
Signal Transduction and Targeted Therapy|May 4, 2026
Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventionsGanji Purnachandra Nagaraju, Haasita Nellipudi, Chaithanya Ganji, et al.
Journal of Surgical Oncology|December 17, 2013
Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinomaWalid L Shaib, Rahul Sharma, Edith Brutcher, et al.
Pageof 20